Sunbelt Securities »

Neurogene shares owned by Sunbelt Securities

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Sunbelt Securities from 13F filings

Historical chart of Sunbelt Securities investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Sunbelt Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Sunbelt Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $40 2 20.00

More positions owned by Sunbelt Securities

Exxon Mobil Corp Stock (XOM)
Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Microsoft Corp Stock (MSFT)
Broadcom Stock (AVGO)
Ishares Gold Trust Etf (IAU)
Invesco Qqq Trust Series I Etf (QQQ)
Schwab U.s. Large-cap Growth Etf Etf (SCHG)
Ishares S&p 500 Growth Etf Etf (IVW)
Ishares Core S&p 500 Etf Etf (IVV)
Bluerock Pvt Real Estate Cef (BPRE)
Alpha Architect 1-3 Month Box Etf Etf (BOXX)
Amazon Stock (AMZN)
Innovator Defined Wealth Shield Etf Etf (BALT)
Schwab U.s. Large-cap Value Etf Etf (SCHV)

View all positions for Sunbelt Securities

Top funds holding Neurogene

Samsara BioCapital
Redmile Group
Casdin Capital
Rtw Investments
EcoR1 Capital
BlackRock
Baker Bros. Advisors
Trails Edge Capital Partners
Balyasny Asset Management
Toronto-Dominion Bank
Vanguard Group
Jennison Associates
Arrowpoint Asset Management
Vanguard Capital Management
Dr. Jeffrey R. Jay, M.D.

View all funds holding Neurogene